Thirona, a Nijmegen, Netherlands-based company specializing in advanced analysis of thoracic CT images with artificial intelligence (AI), has secured €7.5 million in funding.
This funding includes a €5 million investment from HERAN Partners and the Dutch-based Borski Fund, along with a €2.5 million grant from the European Innovation Council (EIC).
Founded in 2020, HERAN Partners is a venture capital firm based in Antwerp, Belgium that prefers to invest in seed-stage, early-stage, and later-stage companies. The firm seeks to invest in healthcare, information technology, life sciences, big data, the internet of things, SaaS, artificial intelligence, machine learning, and technology-based sectors in Europe.
Borski Fund is a venture capital firm that seeks to invest in retail and healthtech sectors. The firm focuses on female entrepreneurs and companies that reduce the gender gap. Founded in 2019 and based in Amsterdam, the Netherlands.
Thirona Use of Funds
The funding will support the company's efforts to advance precision medicine and enhance patient care for lung diseases.
Founded by Eva van Rikxoort in 2014, Thirona is a global company providing high-precision advanced lung image analysis with artificial intelligence through expertise-based services for MedTech, pharmaceutical, and CRO companies. Thirona partners with research institutions and medical companies in their innovation programs aimed to enable breakthroughs in precision medicine for personalized treatment of pulmonary diseases. The company’s mission is to utilize the latest domain knowledge and artificial intelligence technology to create a positive impact by making personalized treatments for lung diseases accessible to everyone.
Company: Thirona BV
Funding Month: September 2023
Lead Investors: HERAN Partners, Borski Fund
Additional Investors: European Innovation Council
Company Website: https://thirona.eu/
Software Category: AI-powered Medical Image Analysis